Showing 101 - 120 results of 22,188 for search '(( 5 step decrease ) OR ((( 50 ((nn decrease) OR (a decrease)) ) OR ( a fold decrease ))))', query time: 0.61s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109

    Response of small airway tissues infected with EV-D94 and decreasing doses of EV-D68. by Ines Cordeiro Filipe (5849144)

    Published 2022
    “…<p>Tissues were infected with 1E7 RNA copies of EV-D94 (equivalent to 2,46E4 TCID50) and 1E7 RNA copies of EV-D68 (3,3E5 TCID50) as well as decreasing doses of the latter. …”
  10. 110
  11. 111

    Giant fiber recordings from 5 day post eclosion flies stimulated at 20 and 50 Hz. by Jose L. Salazar (3233190)

    Published 2021
    “…(B,D) TTM muscles show a small but significant decrease in response probability at 50 Hz but not 20 Hz. …”
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117
  18. 118

    Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa by Andrej Emanuel Cotman (5203904)

    Published 2023
    “…Starting from DNA gyrase inhibitor <b>1</b>, we identified compound <b>27</b>, featuring a 10-fold improved aqueous solubility, a 10-fold improved inhibition of topoisomerase IV from A. baumannii and P. aeruginosa, a 10-fold decreased inhibition of human topoisomerase IIα, and no cross-resistance to novobiocin. …”
  19. 119
  20. 120